There is a large gap in how precision medicine is practiced today. There is a significant need to individualize medicine based on unique patient characteristics and models/algorithms built on large amounts of data. We saw an opportunity to bring these advanced models and algorithms that previously were only available to highly-specialized academic researchers to a wider audience of health care practitioners.
Founded in 2015, InsightRX is a venture backed healthcare technology company based in San Francisco focused on individualizing treatment at the point of care. InsightRX’s precision dosing platform combines patient-specific data with pharmacology models and machine learning to help clinicians individualize dosing for complex medications where a ‘one-size-fits-all’ treatment approach leads to suboptimal clinical outcomes.
InsightRX is integrated into the clinical workflow of healthcare practitioners and supports treatment optimization across several therapeutic areas including antibiotics, chemotherapeutics and immunosuppressants. InsightRX is currently deployed in over 50 top tier medical centers and is partnered with globally recognized biotechnology and pharmaceutical companies to bring precision dosing to the forefront of patient care.